Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 16143 | 670 | 34.3 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
| 1202 | 2 | JOURNAL OF INTERFERON RESEARCH//INTERFERON//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 9220 |
| 16143 | 1 | SECT PHARMACOL MED ONCOL//INTERDIPARTIMENTALE EPIDEMIOL//NIKAIA GEN HOSP | 670 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | SECT PHARMACOL MED ONCOL | address | 136716 | 1% | 50% | 6 |
| 2 | INTERDIPARTIMENTALE EPIDEMIOL | address | 91148 | 0% | 100% | 2 |
| 3 | NIKAIA GEN HOSP | address | 60764 | 0% | 67% | 2 |
| 4 | RECOMBINANT HUMAN INTERFERON ALPHA 2A | authKW | 60764 | 0% | 67% | 2 |
| 5 | ROFERON AR | authKW | 60764 | 0% | 67% | 2 |
| 6 | 5 FLUOROURACIL | authKW | 52540 | 11% | 2% | 71 |
| 7 | 5 FLUOROURACIL CLINICAL PHARMACOKINETICS COMBINATION WITH BIOMODULATORS | authKW | 45574 | 0% | 100% | 1 |
| 8 | 5 FU COLORECTAL CANCER | authKW | 45574 | 0% | 100% | 1 |
| 9 | 9 FLUOROURACIL | authKW | 45574 | 0% | 100% | 1 |
| 10 | ALPHA INTERFERON PHARMACOKINETICS | authKW | 45574 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 14817 | 76% | 0% | 506 |
| 2 | Pharmacology & Pharmacy | 229 | 13% | 0% | 88 |
| 3 | Medicine, Research & Experimental | 159 | 7% | 0% | 46 |
| 4 | Immunology | 126 | 8% | 0% | 56 |
| 5 | Radiology, Nuclear Medicine & Medical Imaging | 17 | 3% | 0% | 22 |
| 6 | Obstetrics & Gynecology | 5 | 2% | 0% | 11 |
| 7 | Infectious Diseases | 2 | 1% | 0% | 9 |
| 8 | Biochemistry & Molecular Biology | 2 | 7% | 0% | 45 |
| 9 | Chemistry, Medicinal | 1 | 1% | 0% | 8 |
| 10 | Urology & Nephrology | 0 | 1% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | SECT PHARMACOL MED ONCOL | 136716 | 1% | 50% | 6 |
| 2 | INTERDIPARTIMENTALE EPIDEMIOL | 91148 | 0% | 100% | 2 |
| 3 | NIKAIA GEN HOSP | 60764 | 0% | 67% | 2 |
| 4 | ARTHUR PURDY STOUT SURG PATHOL | 45574 | 0% | 100% | 1 |
| 5 | BARMHERZIGEN BRUDER | 45574 | 0% | 100% | 1 |
| 6 | BARMHERZIGEN WESTERN | 45574 | 0% | 100% | 1 |
| 7 | CLIN ACTIVITIES | 45574 | 0% | 100% | 1 |
| 8 | DIPARTIMENTO MED SPERIMENTALE ONCOL CLIN | 45574 | 0% | 100% | 1 |
| 9 | DIPARTIMENTO MED SPERIMENTALE ONCOL MED | 45574 | 0% | 100% | 1 |
| 10 | EPIDEMIOL CIN | 45574 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 23926 | 2% | 3% | 16 |
| 2 | JOURNAL OF INTERFERON RESEARCH | 20679 | 3% | 2% | 21 |
| 3 | SEMINARS IN ONCOLOGY | 13292 | 6% | 1% | 39 |
| 4 | GANN | 4931 | 1% | 1% | 9 |
| 5 | CANCER TREATMENT REPORTS | 2959 | 2% | 1% | 12 |
| 6 | ANTICANCER RESEARCH | 2720 | 5% | 0% | 34 |
| 7 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2215 | 3% | 0% | 19 |
| 8 | INVESTIGATIONAL NEW DRUGS | 2143 | 2% | 0% | 11 |
| 9 | CANCER RESEARCH | 2012 | 6% | 0% | 42 |
| 10 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2011 | 1% | 0% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MAKOWER, D , WADLER, S , (1999) INTERFERONS AS BIOMODULATORS OF FLUOROPYRIMIDINES IN THE TREATMENT OF COLORECTAL CANCER.SEMINARS IN ONCOLOGY. VOL. 26. ISSUE 6. P. 663 -671 | 39 | 78% | 23 |
| 2 | WADLER, S , SCHWARTZ, EL , (1990) ANTINEOPLASTIC ACTIVITY OF THE COMBINATION OF INTERFERON AND CYTOTOXIC AGENTS AGAINST EXPERIMENTAL AND HUMAN MALIGNANCIES - A REVIEW.CANCER RESEARCH. VOL. 50. ISSUE 12. P. 3473-3486 | 57 | 53% | 337 |
| 3 | KJAER, M , (1996) COMBINING 5-FLUOROURACIL WITH INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED COLORECTAL CANCER: OPTIMISM FOLLOWED BY DISAPPOINTMENT.ANTI-CANCER DRUGS. VOL. 7. ISSUE 1. P. 35-42 | 30 | 88% | 6 |
| 4 | GRECO, FA , FIGLIN, R , YORK, M , EINHORN, L , SCHILSKY, R , MARSHALL, EM , BUYS, SS , FROIMTCHUK, MJ , SCHULLER, J , SCHUCHTER, L , ET AL (1996) PHASE III RANDOMIZED STUDY TO COMPARE INTERFERON ALFA-2A IN COMBINATION WITH FLUOROURACIL VERSUS FLUOROURACIL ALONE IN PATIENTS WITH ADVANCED COLORECTAL CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 14. ISSUE 10. P. 2674-2681 | 29 | 74% | 51 |
| 5 | SANTHANAM, S , DECATRIS, M , O'BYRNE, K , (2002) POTENTIAL OF INTERFERON-ALPHA IN SOLID TUMOURS - PART 2.BIODRUGS. VOL. 16. ISSUE 5. P. 349-372 | 78 | 23% | 17 |
| 6 | PARKER, BS , RAUTELA, J , HERTZOG, PJ , (2016) ANTITUMOUR ACTIONS OF INTERFERONS: IMPLICATIONS FOR CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 16. ISSUE 3. P. 131 -144 | 39 | 19% | 9 |
| 7 | RADERER, M , SCHEITHAUER, W , (1995) TREATMENT OF ADVANCED COLORECTAL-CANCER WITH 5-FLUOROURACIL AND INTERFERON-ALPHA - AN OVERVIEW OF CLINICAL-TRIALS.EUROPEAN JOURNAL OF CANCER. VOL. 31A. ISSUE 6. P. 1002-1008 | 25 | 69% | 28 |
| 8 | MARSHALL, ME , TANGEN, CM , BERENBERG, JL , BALCERZAK, SP , BROWN, T , MACDONALD, JS , (1994) TREATMENT OF ADVANCED COLORECTAL-CARCINOMA WITH 5-FLUOROURACIL, LEUCOVORIN AND ROFERON-A(R) - A SOUTHWEST ONCOLOGY STUDY-GROUP STUDY.CANCER BIOTHERAPY. VOL. 9. ISSUE 4. P. 301-306 | 22 | 85% | 3 |
| 9 | DANHAUSER, LL , FREIMANN, JH , GILCHRIST, TL , GUTTERMAN, JU , HUNTER, CY , YEOMANS, AC , MARKOWITZ, AB , (1993) PHASE-I AND PLASMA PHARMACOKINETIC STUDY OF INFUSIONAL FLUOROURACIL COMBINED WITH RECOMBINANT INTERFERON-ALFA-2B IN PATIENTS WITH ADVANCED CANCER.JOURNAL OF CLINICAL ONCOLOGY. VOL. 11. ISSUE 4. P. 751-761 | 24 | 71% | 41 |
| 10 | GENNATAS, C , DARDOUFAS, C , MOURATIDOU, D , TSAVARIS, N , POULI, A , ANDROULAKIS, G , PHILIPPAKIS, M , VOROS, D , BATALIS, T , BESBEAS, S , ET AL (2003) SURGICAL ADJUVANT THERAPY OF RECTAL CARCINOMA: A CONTROLLED EVALUATION OF LEUCOVORIN, 5-FLUOROURACIL AND RADIATION THERAPY WITH OR WITHOUT INTERFERON-ALPHA 2B.ANNALS OF ONCOLOGY. VOL. 14. ISSUE 3. P. 378-382 | 16 | 70% | 4 |
Classes with closest relation at Level 1 |